Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Rheumatic Heart Disease Market from 2024 to 2025?

In recent times, there has been a significant expansion in the size of the rheumatic heart disease market. Its growth trajectory is projected to escalate from $2.56 billion in 2024 to $2.72 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The historical growth in this market stems from factors such as the widespread occurrence of untreated strep infections, restricted healthcare accessibility in impoverished areas, a general lack of knowledge about rheumatic heart disease, a lag in diagnosis and treatment, as well as ineffective vaccination programs.

What Is the Projected Market Size of the Rheumatic Heart Disease Market?

In the coming years, the market size of Rheumatic heart disease is projected to experience a strong expansion, elevating to $3.44 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. This surging growth during the projection period can be ascribed to factors such as the rising implementation of preventive screening programs, heightened awareness for early diagnosis, an increase in healthcare investment in developing economies, proliferation of telemedicine for distant diagnosis, and government strategies aimed at disease prevention. The prediction period will also witness trends like escalating utilization of AI for diagnosis, growth of echocardiography-based screening, the adoption of mobile health solutions, the creation of innovative anti-inflammatory treatments, and strategic partnerships for worldwide disease elimination.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23502&type=smp

Who are the Major Competitors in the Rheumatic Heart Disease Market Outlook?

Major companies operating in the rheumatic heart disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc (GSK), Medtronic plc, Siemens Healthineers AG, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Mayo Clinic, Boston Scientific Corporation, Johns Hopkins Medicine, Terumo Corporation, The Mount Sinai Health System Inc., Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta.

What Is Fueling Growth in the Rheumatic Heart Disease Market?

The rise in the occurrence of strep throat is projected to boost the rheumatic heart disease market’s expansion in the future. Strep throat is defined as a bacterial infection instigated by streptococcus pyogenes (group a streptococcus), resulting in inflammation and throat pain, often with fever, heightened lymph nodes, and swallowing difficulty. Growing resistance to antibiotics makes it challenging to treat streptococcal infections effectively, leading to extended sickness and heightened transmission rates in communities. Rheumatic heart disease is a long-lasting complication of recurring or untreated strep throat infections, emphasizing the critical nature of early detection and treatment of streptococcal infections to avoid severe heart damage. The Centers for Disease Control and Prevention, a US government department, reported in April 2023, for example, that strep throat is responsible for approximately 5.2 million annual outpatient visits amongst those under 65 years. These visits result in 2.8 million antibiotic prescriptions each year. Hence, the climbing incidence of strep throat is propelling the rheumatic heart disease market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23502&type=smp

Which Rheumatic Heart Disease Market Segments Are Growing the Fastest?

The rheumatic heart disease market covered in this report is segmented –

1) By Type: Valve, Myocarditis, Pericarditis

2) By Age Group: Pediatric, Adolescent, Adult, Geriatric

3) By Application: Hospital, Diagnostic Centre, Research Centre

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales

Subsegments:

1) By Valve: Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease

2) By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis

3) By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis

Which Industry Trends Are Shaping the Future of the Rheumatic Heart Disease Market?

Leading corporations in the rheumatic heart disease market are utilizing strategic collaborations to pioneer breakthrough therapies and diagnoses. These partnerships within the RHD management arena consolidate resources and know-how, pushing forward research and development, boosting innovation in diagnostics and treatments, broadening market reach, and accelerating product launch. For example, in July 2023, the Switzerland-based World Heart Federation (WHF) forged a partnership with the Philips Foundation, a non-profit organization from the Netherlands, with a mission to heighten awareness, enhance medical education, and promote early detection of RHD in the Asia-Pacific region. Initiated in the Philippines, the project aims at improving healthcare access for more than half a million Filipino children susceptible to the disease by stocking facilities with skilled professionals and state-of-the-art diagnostic tools. This cooperative effort reaffirms their mutual pledge to augment healthcare infrastructure and assure prompt medical attention to patients with RHD.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/rheumatic-heart-disease-global-market-report

Which Countries Are Leading the Rheumatic Heart Disease Market?

North America was the largest region in the rheumatic heart disease market in 2024. The regions covered in the rheumatic heart disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23502

This Report Delivers Insight On:

1. How big is the rheumatic heart disease market, and how is it changing globally?

2. Who are the major companies in the rheumatic heart disease market, and how are they performing?

3. What are the key opportunities and risks in the rheumatic heart disease market right now?

4. Which products or customer segments are growing the most in the rheumatic heart disease market?

5. What factors are helping or slowing down the growth of the rheumatic heart disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model